Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 3284 entries
View as:

ASTERIX: Low Dose ASA and Nexium

Phase: N/A Priority: Normal
NCT ID: NCT00251966 Org: User:
Start: 05/31/04 End: 09/30/05 Due: 09/30/06

A Study of Novel Anti-cancer Agents in Patients With Previously Untreated NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT03819465 Org: User:
Start: 12/27/18 End: 03/26/26 Due: 03/26/27

Symptoms and Physical Activity in COPD Patients in Europe

Phase: N/A Priority: Normal
NCT ID: NCT03031769 Org: User:
Start: 12/21/16 End: 08/31/17 Due: 08/31/18

A Study to Compare if the Uptake of Ticagrelor in the Body Differs When Different Tablets Are Administered

Phase: N/A Priority: Normal
NCT ID: NCT03126695 Org: User:
Start: 05/12/17 End: 07/24/17 Due: 07/24/18

A Study to Test Whether ZS (Sodium Zirconium Cyclosilicate) Can Reduce the Incidence of Increased Blood Potassium Levels Among Dialized Patients.

Phase: N/A Priority: Normal
NCT ID: NCT03303521 Org: User:
Start: 12/14/17 End: 11/07/18 Due: 11/07/19

Bioequivalence Study of Combination Tablets of Saxagliptin / Dapagliflozin / Metformin XR (Extended-release) and Dapagliflozin / Metformin XR Relative to Individual Components in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03138356 Org: User:
Start: 05/25/17 End: 11/28/17 Due: 11/28/18

Prospective Evaluation of Proteinuria and Renal Function in Diabetic Patients With Progressive Renal Disease

Phase: N/A Priority: Normal
NCT ID: NCT00296374 Org: User:
Start: 02/28/06 End: 03/31/09 Due: 03/31/10

Phase IV Study With a 36-week Extension Period to Evaluate the Efficacy and Safety of Dapagliflozin Therapy When Added to the Therapy of Japanese Patients With Type 2 Diabetes With Inadequate Glycemic Control on Insulin.

Phase: N/A Priority: Normal
NCT ID: NCT02157298 Org: User:
Start: 06/30/14 End: 11/30/15 Due: 11/30/16

A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD9977 After Single Ascending Doses to Healthy Males

Phase: N/A Priority: Normal
NCT ID: NCT02484729 Org: User:
Start: 07/31/15 End: 11/30/15 Due: 11/30/16

Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo

Phase: N/A Priority: Normal
NCT ID: NCT02229396 Org: User:
Start: 09/04/14 End: 12/28/17 Due: 12/28/18

Seroquel® Combined With Cognitive Remediation Therapy to Conventional Treatment in Patients With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT00255515 Org: User:
Start: 09/30/05 End: 12/31/07 Due: 12/31/08

Four-week Omeprazole Treatment of Non-erosive Reflux Disease in a Japanese Population

Phase: N/A Priority: Normal
NCT ID: NCT00259077 Org: User:
Start: 10/31/03 End: 07/31/04 Due: 07/31/05

A Study Evaluating the Efficacy and Safety of Adding Symlin® to Lantus® (Insulin Glargine) in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00240253 Org: User:
Start: 10/31/05 End: 06/30/06 Due: 06/30/07

Long-tErm Follow-uP of antithrombotIc Management Patterns In Acute CORonary Syndrome Patients in Asia

Phase: N/A Priority: Normal
NCT ID: NCT01361386 Org: User:
Start: 06/30/11 End: 05/31/14 Due: 05/31/15

A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of MEDI9929 After Single Administration in Healthy Male Japanese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01913028 Org: User:
Start: 08/31/13 End: 01/31/14 Due: 01/31/15

Durvalumab Plus Chemotherapy in ES-SCLC (Oriental)

Phase: N/A Priority: Normal
NCT ID: NCT04449861 Org: User:
Start: 12/07/20 End: 03/30/23 Due: 03/30/24

To Evaluate Patient Preference of Movantik and Polyethylene Glycol 3350 for Opioid Induced Constipation

Phase: N/A Priority: Normal
NCT ID: NCT03060512 Org: User:
Start: 03/02/17 End: 08/23/17 Due: 08/23/18

Evaluate Durvalumab and Tremelimumab +/- Lenvatinib in Combination With TACE in Patients With Locoregional HCC

Phase: N/A Priority: Normal
NCT ID: NCT05301842 Org: User:
Start: 03/28/22 End: 02/26/27 Due: 02/26/28

Study to Evaluate Efficacy, Safety, Tolerability and Pharmacokinetics of AZD1386 in Patients With Peripheral Neuropathic Pain

Phase: N/A Priority: Normal
NCT ID: NCT00976534 Org: User:
Start: 09/30/09 End: 02/28/10 Due: 02/28/11

AZD9742 Single and Multiple Ascending Dose Study in Healthy Male and Female Japanese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01114152 Org: User:
Start: 04/30/10 End: 07/31/10 Due: 07/31/11

Comparison of the Bioavailability of Fenofibric Acid and Rosuvastatin From 5/45 mg Strength of ABT-143 Relative to That From the Coadministration of ABT-335 (Fenofibric Acid) 45 mg and Rosuvastatin Calcium 5 mg

Phase: N/A Priority: Normal
NCT ID: NCT00826358 Org: User:
Start: 11/30/08 End: - Due: -

XIGDUO Extended Release (XR) Post Marketing Surveillance

Phase: N/A Priority: Normal
NCT ID: NCT03038789 Org: User:
Start: 04/20/17 End: 08/30/19 Due: 08/30/20

Esomeprazole for Prevention of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs

Phase: N/A Priority: Normal
NCT ID: NCT00241514 Org: User:
Start: 02/28/01 End: 02/28/03 Due: 02/28/04

Efficacy and Safety Study of Seroquel SR in the Treatment of Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00388973 Org: User:
Start: 09/30/06 End: 12/31/07 Due: 12/31/08

Observational Study of Patients With Locally Advanced or Metastatic NSCLC (Non-Small Cell Lung Cancer)

Phase: N/A Priority: Normal
NCT ID: NCT03053297 Org: User:
Start: 03/01/17 End: 11/08/17 Due: 11/08/18